Casey McPherson

CEO of AlphaRose Therapeutics

Biography

Casey McPherson is an entrepreneur and accomplished singer songwriter. His
accolades include two #10 US hits, #10 video on VH1, and performed globally for
hundreds of thousands of fans.

After his youngest daughter Rose was diagnosed with an ultra rare disease, Casey
spent months learning genetics, drug development, and biotech business. In 2020,
McPherson started To Cure A Rose Foundation to fund a cure for Rose, as well as other
rare disease therapeutics and innovation. In 2022, he confounded TCAR RareLabs (formerly
Everlum Bio), the firstrare disease contract research lab for family run foundations
and rare disease biotechs.

In 2023, Casey spun out AlphaRose, an ultra rare commercialization platform
company for rare diseases, of which he is currently the founder and CEO.

He has a vast network of executives, drug developers, academics, and scientists in rare
disease that he works with regularly. As Casey puts it, “Drug development is not unlike
the music business. It takes grit, humility, creativity, and courage to stay laser focused
on your goal.” Casey lives in Austin, Texas and speaks at conferences across the globe, committed
to his mission to bring treatments to children like his daughter Rose.

Companies

AlphaRose unlocks precision medicines for patients without a cure
Pitch is a Capital Factory product. © Capital Factory 2024. Privacy policy.